Zoetis (ZTS) Leases (2019 - 2026)
Zoetis' (ZTS) quarterly Leases came in at $282.0 million in Q1 2026, up 28.18% year-on-year from $220.0 million in Q1 2025, and down 2.42% on a QoQ basis from $289.0 million in Q4 2025.
Zoetis (ZTS) Leases (2019 - 2026) Analysis & Trends
Zoetis (ZTS) has 8 years of Leases data on file, last reported at $282.0 million in Q1 2026.
- On a quarterly basis, Leases rose 28.18% year-over-year to $282.0 million in Q1 2026; TTM through Mar 2026 was $282.0 million, a 28.18% increase from a year earlier, with the FY2025 full-year figure at $289.0 million, up 31.96% from the prior year.
- Leases for Q1 2026 stood at $282.0 million, down from $289.0 million in the prior quarter.
- Over the last five years, Leases for ZTS reached as high as $302.0 million in Q2 2025 and fell as low as $189.0 million in Q1 2022.
- Historically, Leases has averaged $234.6 million across 5 years, with a median of $223.0 million in 2024.
- Across the five-year window, Leases retreated 4.78% in 2024 and jumped 36.04% in 2025, its largest moves.
- Year by year, Leases stood at $220.0 million in 2022, then gained by 4.55% to $230.0 million in 2023, then slipped by 4.78% to $219.0 million in 2024, then soared by 31.96% to $289.0 million in 2025, then decreased by 2.42% to $282.0 million in 2026.
- Per Business Quant data, the three most recent Leases figures were $282.0 million in Q1 2026, $289.0 million in Q4 2025, and $292.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn | 335.00 Mn |
| 3 | Zoetis | 32.72 Bn | 30.78 Bn | 1.62 Bn | 282.00 Mn |
| 4 | Takeda Pharmaceutical | 27.65 Bn | 23.59 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.11 Bn | 20.96 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | 1.06 Mn |
| 7 | Viatris | 20.30 Bn | 18.50 Bn | 1.16 Bn | 253.00 Mn |
| 8 | Neurocrine Biosciences | 17.88 Bn | 16.56 Bn | 800.70 Mn | 447.10 Mn |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn | 84.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 282.00 Mn |
| Dec 31, 2025 | 289.00 Mn |
| Sep 30, 2025 | 292.00 Mn |
| Jun 30, 2025 | 302.00 Mn |
| Mar 31, 2025 | 220.00 Mn |
| Dec 31, 2024 | 219.00 Mn |
| Sep 30, 2024 | 223.00 Mn |
| Jun 30, 2024 | 222.00 Mn |
| Mar 31, 2024 | 225.00 Mn |
| Dec 31, 2023 | 230.00 Mn |
| Sep 30, 2023 | 226.00 Mn |
| Jun 30, 2023 | 224.00 Mn |
| Mar 31, 2023 | 216.00 Mn |
| Dec 31, 2022 | 220.00 Mn |
| Sep 30, 2022 | 217.00 Mn |
| Jun 30, 2022 | 193.00 Mn |
| Mar 31, 2022 | 189.00 Mn |
| Dec 31, 2021 | 181.00 Mn |
| Sep 30, 2021 | 188.00 Mn |
| Jun 30, 2021 | 177.00 Mn |